Breaks Categories: News

ThursdayMay 16, 2024 1:56 pm

NetworkNewsBreaks – Sow Good Inc. (NASDAQ: SOWG) Closes Overallotment Option in $13.8M Public Offering

Sow Good (NASDAQ: SOWG), a trailblazer in the freeze dried candy and treat industry, recently announced that the underwriters of its completed public offering of common stock had purchased 180,000 shares of its common stock. The underwriters made the purchase upon full exercise of their option to purchase additional shares of common stock to cover overallotments at the initial offering price of $10.00 per unit. Including proceeds from the sale of additional shares, the offering yielded approximately $13.8 million in gross proceeds before deductions. Roth Capital Partners acted as sole book-running manager for the offering, while Craig-Hallum acted as the…

Continue Reading

ThursdayMay 16, 2024 1:54 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting its financial and business results for the first quarter 2024, the period ended March 31, 2024. A highlight of the report was that enrollment is nearly completed in a potentially pivotal GBM study evaluating Berubicin with topline data expected in the first half of 2025. In addition, financial results showed a net loss for the quarter of approximately $3.5 million, down from an estimated $4.9 million net loss for the comparable period…

Continue Reading

ThursdayMay 16, 2024 1:46 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Achieves Record Profit, 400% YoY EBITDA Growth for Q1 2024

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, IoT and cybersecurity sectors, has announced results for the three months ended March 31, 2024. Among the highlights, the company reported an 8% increase in revenue to $6.9 million from $6.4 million and 139% increase in gross profit to $3.8 million from $1.6 million compared to the first quarter of 2023. “We are pleased to report a strong start to 2024, marked by significant financial and operational achievements. This quarter, we’ve continued to see revenue growth YoY and a dramatic improvement in our profitability metrics leading to an…

Continue Reading

ThursdayMay 16, 2024 1:16 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Names Seasoned Business Leader to Board of Directors

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical solutions, has announced a new member of its board of directors. According to the announcement, Sergei Glinka, a seasoned and highly respected business executive, will serve on the board. An Estonian citizen, Glinka has served in several executive and board roles positions in large European companies, including Automecanica Skb Property Srl., GST Investments OU and TG Biochemicals Ltd. Glinka’s expertise will support and facilitate new licensing and networking opportunities for Nutriband throughout Europe as the company works to expand its AVERSA(TM) technology, which is patented in 45 countries. The announcement noted that…

Continue Reading

ThursdayMay 16, 2024 1:02 pm

NetworkNewsBreaks – Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Acquires Additional Contiguous Claims at Kenbridge Nickel Project, Reports Start of 2024 Baseline Study

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA), a Canadian-based company specializing in mineral exploration and development, is announcing the acquisition of additional contiguous claims at the Kenbridge Nickel Project, Northwestern Ontario. Following the acquisition, the total property now consists of 93 contiguous patents, 153 single cell mining claims and 4 Mining Licenses, covering a total of 4,273 ha. According to the announcement, the patents and staked cells are owned 100% by Tartisan Nickel through wholly owned subsidiaries. The company also announced that Aspen Biological Ltd. staff have commenced the 2024 baseline study fieldwork, which includes completing the baseline aquatic…

Continue Reading

ThursdayMay 16, 2024 1:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases FY 2023 Financial Results, Provides Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting its full-year financial results for 2023 along with a company update. Highlights of the report included news that, in the first four months of 2024, the company has received CDMO work orders valued at approximately $500,000, with current guidance for this year of approximately $1.25 million in expected revenues. The report also noted that the company is “aggressively advancing” its NanoAb preclinical development, with promising results obtained in a…

Continue Reading

ThursdayMay 16, 2024 10:55 am

NetworkNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) CEO Shares Shareholder Letter, Corporate Update

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, and its chair and CEO Robert Nistico have released a letter to shareholders. In the letter, Nistico shared information from the company’s first-quarter 2024 results, along with a corporate update. Notable numbers from the quarter include sales of $1.2 million from the company’s branded beverage division, down from $1.9 million over the same period last year, with the company’s eCommerce division, Qplash, reporting shipments “well below” demand and capabilities. Nistico provided an explanation for the lower numbers, noting that the company reports revenue from shipments to distributors, which typically maintain…

Continue Reading

WednesdayMay 15, 2024 2:51 pm

NetworkNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Featured in Couloir Capital Report with ‘Buy’ Recommendation

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced-stage, gold-exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project, is spotlighted in a recent Couloir Capital Report. Couloir Capital is a research-driven investment dealer focused on emerging companies in the natural-resources sector. The report recommends Emperor Metals as a Buy with high risk and an initial fair market value target of $0.72. The report notes several investment highlights, including the company’s focus on expanding resource on the project through 3D modeling of resource targets and successful drilling programs and its option to acquire…

Continue Reading

WednesdayMay 15, 2024 2:22 pm

NetworkNewsBreaks – EF Hutton Collaborates with IBN to Provide Coverage, Elevate Visibility of Annual Global Conference

EF Hutton, a fast-paced, high-growth investment bank founded by experienced investment professionals, is working with IBN (“InvestorBrandNetwork”), a cutting-edge corporate communications firm and content distributor; IBN is an official media sponsor for today’s EF Hutton Annual Global Conference in New York City. As a media sponsor, IBN has focused on elevating the visibility of today’s event through amplified article syndication as well as an array of digital solutions designed increase recognition of participating companies and conference sponsors. As part of those efforts, IBN provided its audiences with summaries on each participating company and issued a special conference-focused email broadcast to subscribers of…

Continue Reading

WednesdayMay 15, 2024 2:21 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Q1 2024 Results, Renews Agreement with the University of Southern California to Advance Annealing Quantum Computing Research and Adoption

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, has announced financial results for its first fiscal quarter ended March 31, 2024. Q1 revenues were up more than 50% year over year and Q1 gross profit surged 294% year over year. “We believe D-Wave’s first quarter revenue and bookings reflect growing customer demand for quantum and hybrid quantum solutions that can drive measurable impact today,” said Dr. Alan Baratz, CEO of D-Wave. “Coupled with the significant technical milestones we’ve achieved with the Advantage2™ prototype, we believe our progress leading the commercialization of quantum is…

Continue Reading